ANIP vs GILD · rev $503.5M vs P/E 18, rev $7.80B
ANI Pharmaceuticals Inc (ANIP) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ANIP currently screens at market cap $1.41B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ANIP and GILD stock pages for the full models.
Not investment advice.